Oral cimetidine gives effective symptom relief in painful bladder disease: A prospective, randomized, double-blind placebo-controlled trial

BJU International

Volumn 87, Issue 3, 2001, Pages 207-212

  Thilagarajah, R ^a   O'N Witherow, R ^a   Walker, M M ^a,b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cimetidine; Interstitial cystitis; Painful bladder disease

Indexed keywords

CIMETIDINE; COLLAGEN; GLYCOSAMINOGLYCAN;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; DOUBLE BLIND PROCEDURE; DYSURIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NOCTURIA; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; AGED; ANALGESICS, NON-NARCOTIC; BIOPSY; CIMETIDINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PROSPECTIVE STUDIES; URINARY BLADDER DISEASES;

EID: 0035129187     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2001.02031.x     Document Type: Article

References (39)

1. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis
2. Quantitative histopathology can aid diagnosis in painful bladder syndrome
3. Painful bladder syndrome-a clinical and immunopathological study
4. Pathology, pathophysiology, and pathogenesis of painful bladder diseases
5. Histamine content and mast cell count of detrusor muscle in patients with interstitial cystitis and other types of chronic cystitis
6. Mast cells in interstitial cystitis
7. The role of the mast cell in interstitial cystitis
8. Definition and antagonism of histamine H2-receptors
9. Characterization and development of cimetidine as a histamine H2-receptor antagonist
10. Interstitial cystitis 1987
11. Cimetidine in the treatment of interstitial cystitis
12. Cimetidine in the treatment of interstitial cystitis
13. Genotoxicity studies of gastric acid inhibiting drugs
14. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations
15. Should safety concerns with available ulcer treatment influence drug selection?
16. A rare type of bladder ulcer in women; report of cases
17. Surgical management of the painful bladder
18. Treatment of voiding complaints and incontinence in painful bladder syndrome
19. Interstitial cystitis: Early diagnosis, pathology, and treatment
20. Interstitial cystitis treated by prolonged bladder distension
21. Electron microscopic investigation of the bladder urothelium and glycocalyx in patients with interstitial cystitis
22. Urinary excretion of a metabolite of histamine (1.4-methyl-imidazole-acetic-acid) in painful bladder disease
23. Characteristics of mast cells in normal bladder, bacterial cystitis and interstitial cystitis
24. Increased mast cells of the bladder in suspected cases of interstitial cystitis: A possible disease marker
25. Role of surface mucin in primary antibacterial defense of bladder
26. Bladder surface mucin. Its antibacterial effect against various bacterial species
27. Lumenal plasma membrane of the urinary bladder. I. Three-dimensional reconstruction from freeze-etch images
28. Nerve fibre proliferation in interstitial cystitis
29. Interstitial cystitis: Bladder mucosa lymphocyte immunophenotyping and peripheral blood flow cytometry analysis
30. Interstitial cystitis: A review of immunological aspects of the aetiology and pathogenesis, with a hypothesis
31. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes
32. Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-alpha and IL-1 beta production by human monocytes
33. A controlled study of dimethyl sulfoxide in interstitial cystitis
34. Immunologic effects of cimetidine: Potential uses
35. Receptors for histamine can be detected on the surface of selected leukocytes
36. Modulation of cellular immune function in vitro by histamine receptor-bearing lymphocytes: Mechanism of action
37. A technique for the flow cytometric analysis of lymphocytes bearing histamine receptors
38. Mediators of immunity: Lymphokines and monokines